Artemether + Lumefantrine in pharma franchise in Kerala

Artemether + Lumefantrine in PCD pharma franchise in Dispur

Artemether + Lumefantrine in top pharma company in Agra

Artemether + Lumefantrine in pcd pharma supplier in Nashik

Artemether + Lumefantrine in phama franchise company in India
Artemether + Lumefantrine in phama distributor in Faridabad

Home/Products /artemether-20mg-lumefantrine-120mg-tablet

About the Product

Description


Arteslide L 20 Tablet is a potent antimalarial medication designed for the effective treatment of uncomplicated malaria caused by Plasmodium falciparum. The combination of Artemether, a fast-acting antimalarial derived from artemisinin, and Lumefantrine, a long-acting agent, ensures the rapid elimination of malaria parasites while preventing recurrence. This dual-action mechanism targets the parasites at various stages of their lifecycle, reducing the severity of symptoms and aiding in complete recovery.

This formulation is specifically tailored for pediatric patients and those requiring lower dosages to accommodate individual treatment needs. Arteslide L 20 Tablet provides quick relief from malaria-induced symptoms such as fever, chills, fatigue, and body aches, ensuring comprehensive treatment. It is a crucial component of malaria management in endemic regions, offering a reliable solution to combat this life-threatening disease.

Common side effects include nausea, vomiting, headache, dizziness, abdominal pain, or weakness. Rare side effects may include heart rhythm disturbances or allergic reactions.

Indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum, especially in pediatric patients or those requiring a lower dose.

Complete the prescribed course to ensure effective parasite clearance and prevent resistance. Use strictly under medical supervision.

Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Artemether 20mg + Lumefantrine 120mg Tablet in the PCD pharma franchise market?

This anti-malarial combination tablet has strong demand in the infectious disease and tropical healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-infective and malaria care portfolios.

Why should medical distributors include this anti-malarial combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for treatment and management of malaria and related parasitic infections, especially in malaria-prone regions. Artemether works rapidly to reduce malaria parasites in the bloodstream, while Lumefantrine helps eliminate remaining parasites and prevent recurrence, strengthening a reliable anti-malarial product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this anti-malarial combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong demand in anti-malarial therapy, institutional and regional healthcare supply opportunities, reliable supply chain support, and good margins when partnering for this anti-infective product.

How can I become a distributor or franchise partner for this anti-malarial combination tablet?

Medical distributors, stockists, and wholesalers interested in this anti-malarial combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.